Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease: A meta-analysis of randomized controlled trials

European Heart Journal

Volumn 25, Issue 1, 2004, Pages 69-80

  Nordmann, Alain J ^a   Hengstler, Peter ^b   Leimenstoll, Bernd M ^b   Harr, Thomas ^b   Young, James ^a   Bucher, Heiner C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Angioplasty; Coronary artery disease; Meta analysis; Stents

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; FEMALE; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MALE; META ANALYSIS; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; HOSPITAL MORTALITY; HUMANS; RANDOMIZED CONTROLLED TRIALS; STENTS; TREATMENT OUTCOME;

EID: 0347988294     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.10.001     Document Type: Review

References (57)

1. Sigwart U, Puel J, Mirkovitch V et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-6.
2. Curfman GD. Sirolimus-eluting coronary stents. N Engl J Med 2002;346:1770-1.
3. Eeckhout E, Wijns W, Meier B et al. Indications for intracoronary stent placement: the European view. Working Group on Coronary Circulation of the European Society of Cardiology. Eur Heart J 1999;20:1014-9.
4. Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501.
5. The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1998;352:87-92.
6. Weaver WD, Reisman MA, Griffin JJ et al. Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial. Lancet 2000;355:2199-203.
7. Morice MC, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
8. Park SJ, Shim WH, Ho DS et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003;348:1537-45.
9. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
10. Cicchetti DV, Feinstein AR. High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol 1990;43:551-8.
11. Egger M, Davey SG, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
12. Sutton A, Cooper N, Lambert P et al. Meta-analysis of rare and adverse event data [abstr]. Pharmacoecon Outcom Res 2002;2:367.
13. Smeeth L, Haines A, Ebrahim S. Numbers needed to treat derived from meta-analyses - sometimes informative, usually misleading. BMJ 1999;318:1548-51.
14. Engels EA, Schmid CH, Terrin N. Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Stat Med 2000;19:1707-28.
15. Deeks J, Bradburn M, Locatio R et al. Much ado about nothing: Meta-analysis for rare events. 6th Cochrane Colloquium Baltimore, MD, USA 0 AD.
16. Sweeting M, Sutton A, Lambert P What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of rare events, July 2, 2002; 4th symposium on systematic reviews: pushing the boundaries. Oxford, UK.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
18. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121-45.
19. Macaya C, Serruys PW, Ruygrok P et al. Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group. J Am Coll Cardiol 1996;27:255-61.
20. Kiemeneij F, Serruys PW, Macaya C et al. Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. J Am Coll Cardiol 2001;37:1598-603.
21. Lincoff AM, Califf RM, Motiterno DJ et al. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. N Engl J Med 1999;341:319-27.
22. George CJ, Baim DS, Brinker JA et al. One-year follow-up of the Stent Restenosis (STRESS I) Study. Am J Cardiol 1998;81:860-5.
23. Doucet S, Schalij MJ, Vrolix MC et al. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation 2001;104:2029-33.
24. Moer R, Myreng Y, Molstad P et al. Stenting in small coronary arteries (SISCA) trial. A randomized comparison between balloon angioplasty and the heparin-coated beStent. J Am Coll Cardiol 2001;38:1598-603.
25. Kastrati A, Schomig A, Dirschinger J et al. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries. Circulation 2000;102:2593-8.
26. Niazi K. Stents in small coronary vessels: A prospective, randomized study [abstr]. Circulation 1999;Supplement 1:1-510.
27. Park SW, Lee CW, Hong MK et al. Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries. Eur Heart J 2000;21:1785-9.
28. Koning R, Eltchaninoff H, Commeau P et al. Stent placement compared with balloon angioplasty for small coronary arteries: in-hospital and 6-month clinical and angiographic results. Circulation 2001;104:1604-8.
29. Dangas G, Ambrose JA, Rehmann D et al. Balloon optimization versus stent study (BOSS): provisional stenting and early recoil after balloon angioplasty. Am J Cardiol 2000;85:957-61.
30. Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-95.
31. Di Mario C, Moses JW, Anderson TJ et al. Randomized comparison of elective stent implantation and coronary balloon angioplasty guided by online quantitative angiography and intracoronary Doppler. DESTINI Study Group (Doppler Endpoint STenting INternational Investigation). Circulation 2000;102:2938-44.
32. Witkowski A, Ruzyllo W, Gil R et al. A randomized comparison of elective high-pressure stenting with balloon angioplasty: six-month angiographic and two-year clinical follow-up. On behalf of AS (Angioplasty or Stent) trial investigators. Am Heart J 2000;140:264-71.
33. Fluck DS, Chenu P, Mills P et al. Is provisional stenting the effective option? The WIDEST study (Wiktor stent in de novo stenosis). Widest Trial Investigators' Group. Heart 2000;84:522-8.
34. Serruys PW, van Hout B, Bonnier H et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998;352:673-81.
35. Betriu A, Masotti M, Serra A et al. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. J Am Coll Cardiol 1999;34:1498-506.
36. Versaci F, Gaspardone A, Tomai F et al. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 1997;336:817-22.
37. Hardy RJ, Thompson SG. Detecting and describing heterogeneity in meta-analysis. Stat Med 1998;17:841-56.
38. Baim DS, Cutlip DE, O'Shaughnessy CD et al. Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol 2001;87:152-6.
39. Baim DS, Cutlip DE, Midei M et al. Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol 2001;87:157-62.
40. Heuser R, Lopez A, Kuntz R et al. SMART: The microstent's ability to limit restenosis trial. Cathet Cardiovasc Interv 2001;52:269-77.
41. Nageh T, de Belder AJ, Thomas MR et al. A randomised trial of endoluminal reconstruction comparing the NIR stent and the Wallstent in angioplasty of long segment coronary disease: results of the RENEWAL Study. Am Heart J 2001;141:971-6.
42. Han RO, Schwartz RS, Kobayashi Y et al. Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis. Am J Cardiol 2001;88:253-9.
43. Miketic S, Carlsson J, Tebbe U. Randomized comparison of J&J Crown stent versus NIR stent after routine coronary angioplasty. Am Heart J 2001;142:E8.
44. Mehilli J, Kastrati A, Dirschinger J et al. A randomized trial comparing the hand-mounted JoStent with the premounted Multi-Link Duet stent in patients with coronary artery disease. Cathet Cardiovasc Interv 2001;54:414-9.
45. Lansky AJ, Roubin GS, O'Shaughnessy CD et al. Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses. Circulation 2000;102:1364-8.
46. Ashby DT, Dangas G, Aymong EA et al. Relation between the degree of procedural anticoagulation and complications after coronary stent implantation. Am J Cardiol 2003;92:319-22.
47. Yock CA, Boothroyd DB, Owens DK. Projected long-term costs of coronary stenting in multivesset coronary disease based on the experience of the Bypass Angioplasty Revascularization Investigation (BARI). Am Heart J 2000;140:556-64.
48. Brophy JM, Belisle P, Joseph L. Evidence for use of coronary stents. A hierarchical bayesian meta-analysis. Ann Intern Med 2003;138:777-86.
49. Mercado N, Maier W, Boersma E et al. Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty and coronary stenting. Implications for mechanical plaque sealing. Eur Heart J 2003;24:541-51.
50. Zhu MM, Feit A, Chadow H et al. Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials. Am J Cardiol 2001;88:297-301.
51. Keller PF, Verin V, Ziegler T et al. Gamma-irradiation markedly inhibits the hydrated collagen gel contradiction by arterial smooth muscle cells. J Investig Med 2001;49:258-64.
52. Diegeler A, Thiele H, Falk V et al. Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Engl J Med 2002;347:561-6.
53. Van Hout BA, van der WT, de Jaegere PP et al. Cost effectiveness of stent implantation versus PTCA: the BENESTENT experience. Semin Interv Cardiol 1996;1:263-8.
54. Cohen DJ, Krumholz HM, Sukin CA et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators. Circulation 1995;92:2480-7.
55. Peterson ED, Cowper PA, DeLong ER et al. Acute and long-term cost implications of coronary stenting. J Am Coll Cardial 1999;33:1610-8.
56. Eeckhout E, Stauffer JC, Vogt P et al. Comparison of elective Wiktor stent placement with conventional balloon angioplasty for new-onset lesions of the right coronary artery. Am Heart J 1996;132:263-8.
57. Buller CE, Dzavik V, Carere RG et al. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation 1999;100:236-42.